Orphan designation granted for MPSIII

Orphan designation (EU/3/12/980) was granted by the European Commission to Axcentua Pharmaceuticals AB for genistein sodium salt dehydrate (genistein-SSDH) or AXP107-11 for the treatment of mucopolysaccharidosis type III (Sanfilippo syndrome).